Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.

Alnylam Pharmaceuticals

Beam Therapeutics

Bluebird Bio

Prime Medicine

Quanterix

Resilience

Codiak Biosciences

Twist Bioscience

UNITY Biotechnology

VBI Vaccines

Verve Therapeutics

Vir Biotechnology

Gossamer Bio

Grail

Homology Medicines

Juno Therapeutics

Karuna Therapeutics

Kura Oncology

SAGE Therapeutics

Sana Biotechnology

Denali Therapeutics

EQRx

Erasca

Lyell Immunopharma

Illumina

Fate Therapeutics

Scholar Rock

ARCH Venture Partners

HSTS

Person Schema

U.S. Server Location

Gravatar Profiles

AddThis

Oracle Cloud

Co-Founder

Christina Trojel-Hansen

Legal

Jason Doren

Managing Dir/ CFO & CAO

Mark Mcdonnell

Finance and Administration

Zachary Wensch

Director, US Field Operations

Allison Hurst

Principal

Carol Suh

Corey Ritter

Director of IT

Edward H.

Managing Director

Kristina Burow

Director, Operations

Melanie Davis

Maurice Treacy

Steven Gillis

Keith Crandell

Founder and Managing Director

Robert Nelsen

Co-Founder & Managing Director

Clinton Bybee

Co-Founder and Managing Director

Mark McDonnell

Managing Director, Chief Financial and Chief Administrative Officer

Steven Lazarus

Co-founder and Managing Director, Emeritus Chicago

Hong Hou

Venture Partner

Cindy Bayley

Affiliate

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Investors Active in Midwestern US

Seed Stage Investors with Investments in Northeastern US

Late Stage Venture Investors with Investments in New England

Investors with Funds Raised in 2014

ARCH invests primarily in companies co-founded by scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories.

ARCH has raised ten venture funds totaling over $3 billion and has invested in the venture capital rounds for more than 150 companies. ARCH investors include corporations, pension funds, endowment funds, financial institutions, and private investors.

Arch Venture Fund XIII

Arch Venture Fund XII

Arch Venture Fund XI

ARCH Venture Fund X

ARCH Venture Fund IX

ARCH Venture Fund VIII

ARCH Venture Fund VII

ARCH Venture Fund VI

ARCH Venture Fund V

ARCH Venture Fund IV

Chicago

Illinois

United States

North America

The Week’s Biggest Funding Rounds: Food Delivery Startup Wonder Leads Big Week

The Week’s 10 Biggest Funding Rounds: Seaport Therapeutics And Zip Top Big Money Week

The Week’s 10 Biggest Funding Rounds: Form Energy Powers Up With $405M

The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme

Canada

India

Asia

Hong Kong

Philippines

HTML5

F5 NGINX

Modernizr

Wordpress

jQuery

Google Analytics

Microsoft Outlook

Google Compute Engine

Google Tag Manager

Comodo PositiveSSL Certificates

ARCH Venture Partners is an American venture capital firm that primarily invests in companies in the biotechnology industry, as well as in other industries such as semiconductors and technology. The firm was initially created by the University of Chicago and the Argonne National Laboratory to commercialize their technology, and it has since become an independent firm with a focus on investing in transformative and bold ideas.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	3f585059
crunchbase profile	general	Nov 22, 2024 8:49 AM	d3787415
li profile	general	Feb 2, 2024 11:18 PM	6dcfb316
translate crunchbase fundingrounds	general	Nov 22, 2024 11:00 AM	ec54761f
peers	general	Feb 2, 2024 11:18 PM	f8fdf749
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ARCHVENTURE

ARCH Venture Partners